vs
Side-by-side financial comparison of Ameris Bancorp (ABCB) and BALCHEM CORP (BCPC). Click either name above to swap in a different company.
Ameris Bancorp is the larger business by last-quarter revenue ($314.4M vs $270.7M, roughly 1.2× BALCHEM CORP). Ameris Bancorp runs the higher net margin — 35.1% vs 14.9%, a 20.3% gap on every dollar of revenue. On growth, Ameris Bancorp posted the faster year-over-year revenue change (10.0% vs 8.1%). Over the past eight quarters, BALCHEM CORP's revenue compounded faster (7.5% CAGR vs 2.3%).
Ameris Bancorp is an American bank holding company headquartered in Atlanta, Georgia. Through its bank subsidiary, Ameris Bank, the company operates full-service branches in Georgia, Alabama, Florida, North Carolina and South Carolina, and mortgage-only locations in Georgia, Alabama, Florida, North Carolina, South Carolina, Virginia, Maryland, and Tennessee. The company offers online and mobile banking options for both consumers and businesses.
Balchem Corp is a global specialty chemicals and nutritional ingredients provider that develops, manufactures and distributes application-specific products for human nutrition, animal health, pharmaceutical and industrial end markets, serving customers across North America, Europe and Asia Pacific.
ABCB vs BCPC — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $314.4M | $270.7M |
| Net Profit | $110.5M | $40.3M |
| Gross Margin | — | — |
| Operating Margin | — | 20.5% |
| Net Margin | 35.1% | 14.9% |
| Revenue YoY | 10.0% | 8.1% |
| Net Profit YoY | — | 8.7% |
| EPS (diluted) | $1.63 | $1.25 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $314.4M | $270.7M | ||
| Q4 25 | $307.1M | $263.6M | ||
| Q3 25 | $314.2M | $267.6M | ||
| Q2 25 | $300.7M | $255.5M | ||
| Q1 25 | $285.9M | $250.5M | ||
| Q4 24 | $290.8M | $240.0M | ||
| Q3 24 | $283.8M | $239.9M | ||
| Q2 24 | $300.6M | $234.1M |
| Q1 26 | $110.5M | $40.3M | ||
| Q4 25 | $108.4M | $39.2M | ||
| Q3 25 | $106.0M | $40.3M | ||
| Q2 25 | $109.8M | $38.3M | ||
| Q1 25 | $87.9M | $37.1M | ||
| Q4 24 | $94.4M | $33.6M | ||
| Q3 24 | $99.2M | $33.8M | ||
| Q2 24 | $90.8M | $32.1M |
| Q1 26 | — | — | ||
| Q4 25 | — | 35.6% | ||
| Q3 25 | — | 35.7% | ||
| Q2 25 | — | 36.4% | ||
| Q1 25 | — | 35.2% | ||
| Q4 24 | — | 36.0% | ||
| Q3 24 | — | 35.6% | ||
| Q2 24 | — | 35.5% |
| Q1 26 | — | 20.5% | ||
| Q4 25 | 45.9% | 19.8% | ||
| Q3 25 | 43.6% | 20.4% | ||
| Q2 25 | 47.4% | 20.1% | ||
| Q1 25 | 39.5% | 20.4% | ||
| Q4 24 | 43.3% | 19.8% | ||
| Q3 24 | 44.4% | 20.0% | ||
| Q2 24 | 42.1% | 19.6% |
| Q1 26 | 35.1% | 14.9% | ||
| Q4 25 | 44.2% | 14.9% | ||
| Q3 25 | 33.7% | 15.1% | ||
| Q2 25 | 36.5% | 15.0% | ||
| Q1 25 | 30.8% | 14.8% | ||
| Q4 24 | 42.5% | 14.0% | ||
| Q3 24 | 35.0% | 14.1% | ||
| Q2 24 | 30.2% | 13.7% |
| Q1 26 | $1.63 | $1.25 | ||
| Q4 25 | $1.59 | $1.21 | ||
| Q3 25 | $1.54 | $1.24 | ||
| Q2 25 | $1.60 | $1.17 | ||
| Q1 25 | $1.27 | $1.13 | ||
| Q4 24 | $1.35 | $1.03 | ||
| Q3 24 | $1.44 | $1.03 | ||
| Q2 24 | $1.32 | $0.98 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $72.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $4.1B | $1.3B |
| Total Assets | $28.1B | $1.7B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $72.9M | ||
| Q4 25 | — | $74.6M | ||
| Q3 25 | — | $65.1M | ||
| Q2 25 | — | $65.4M | ||
| Q1 25 | — | $49.9M | ||
| Q4 24 | — | $49.5M | ||
| Q3 24 | — | $73.7M | ||
| Q2 24 | — | $63.7M |
| Q1 26 | $4.1B | $1.3B | ||
| Q4 25 | $4.1B | $1.3B | ||
| Q3 25 | $4.0B | $1.3B | ||
| Q2 25 | $3.9B | $1.3B | ||
| Q1 25 | $3.8B | $1.2B | ||
| Q4 24 | $3.8B | $1.1B | ||
| Q3 24 | $3.7B | $1.2B | ||
| Q2 24 | $3.6B | $1.1B |
| Q1 26 | $28.1B | $1.7B | ||
| Q4 25 | $27.5B | $1.7B | ||
| Q3 25 | $27.1B | $1.7B | ||
| Q2 25 | $26.7B | $1.7B | ||
| Q1 25 | $26.5B | $1.6B | ||
| Q4 24 | $26.3B | $1.6B | ||
| Q3 24 | $26.4B | $1.6B | ||
| Q2 24 | $26.5B | $1.6B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $40.1M |
| Free Cash FlowOCF − Capex | — | $33.8M |
| FCF MarginFCF / Revenue | — | 12.5% |
| Capex IntensityCapex / Revenue | — | 2.3% |
| Cash ConversionOCF / Net Profit | — | 0.99× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $40.1M | ||
| Q4 25 | $390.2M | $67.3M | ||
| Q3 25 | $104.9M | $65.6M | ||
| Q2 25 | $61.4M | $47.3M | ||
| Q1 25 | $116.9M | $36.5M | ||
| Q4 24 | $154.2M | $52.3M | ||
| Q3 24 | $102.2M | $51.3M | ||
| Q2 24 | $-97.1M | $45.0M |
| Q1 26 | — | $33.8M | ||
| Q4 25 | $369.6M | — | ||
| Q3 25 | $100.5M | — | ||
| Q2 25 | $53.7M | — | ||
| Q1 25 | $114.2M | — | ||
| Q4 24 | $140.7M | — | ||
| Q3 24 | $99.8M | — | ||
| Q2 24 | $-100.3M | — |
| Q1 26 | — | 12.5% | ||
| Q4 25 | 120.4% | — | ||
| Q3 25 | 32.0% | — | ||
| Q2 25 | 17.9% | — | ||
| Q1 25 | 39.9% | — | ||
| Q4 24 | 48.4% | — | ||
| Q3 24 | 35.2% | — | ||
| Q2 24 | -33.4% | — |
| Q1 26 | — | 2.3% | ||
| Q4 25 | 6.7% | — | ||
| Q3 25 | 1.4% | — | ||
| Q2 25 | 2.5% | — | ||
| Q1 25 | 0.9% | — | ||
| Q4 24 | 4.6% | — | ||
| Q3 24 | 0.8% | — | ||
| Q2 24 | 1.1% | — |
| Q1 26 | — | 0.99× | ||
| Q4 25 | 3.60× | 1.72× | ||
| Q3 25 | 0.99× | 1.63× | ||
| Q2 25 | 0.56× | 1.23× | ||
| Q1 25 | 1.33× | 0.98× | ||
| Q4 24 | 1.63× | 1.56× | ||
| Q3 24 | 1.03× | 1.52× | ||
| Q2 24 | -1.07× | 1.40× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
